In the present study, we found that TP5 can directly inhibit cultured colon cancer stem cells in medium without serum, and reduce the expression of cancer stem cell markers: CD44, CD24 and CD133, and stem-cell related genes: ALDH2, SOX2, OCT4 and Nanog. Here, NANOG is linked to malignant colon neoplasm.